| Name | Title | Contact Details |
|---|
Cameron Miller is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New England Home Therapies is a Southborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mission Canon Medical Systems USA delivers innovative imaging solutions and services through our Made for Life philosophy to improve the quality of life for all people. Our Heritage Canon Medical Systems is born from two global leaders—Canon and Toshiba Medical. In business for more than 100 years` Toshiba Medical was built to improve the quality of life for all people. It delivered on this mission with medical innovations that are Made for Life—made to improve the lives of patients` clinicians and administrators. Its legacy was built with pioneering medical technology` such as the world`s first X-ray machines in 1932 and Japan`s first Magnetic Resonance Imaging systems (MRI) in 1983. Toshiba Medical`s vision was strengthened in 2016 with its acquisition by Canon. Canon entered the healthcare business in 1940 with the development of Japan`s first indirect X-ray camera which was used for the early detection of pulmonary tuberculosis. The partnership of these two companies (now Canon Medical Systems Corporation)` brings together two cutting-edge technology businesses` founded with similar values of creativity` flexibility and patient-friendly healthcare solutions. Today` their combined history of research and innovation drive forward Canon Medical Systems` vision for building a world-class healthcare enterprise.
Surgical Equipment People, The is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe